Artwork

内容由Suno India提供。所有播客内容(包括剧集、图形和播客描述)均由 Suno India 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Man who turned blind after taking kala azar medicine regain vision after surgery

11:10
 
分享
 

Manage episode 420452803 series 2533765
内容由Suno India提供。所有播客内容(包括剧集、图形和播客描述)均由 Suno India 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In April 2024, that is last month, Suno India published the story featuring Iliyas Marandi, a 23-year-old tribal man who lost his eyesight after taking miltefosine drug for Post-Kala-azar Dermal Leishmaniasis, a skin manifestation of the deadly Kala-azar. This May, he underwent a corneal implant surgery at Indira Gandhi Institute of Medical Sciences. Suno India’s Menaka Rao spoke to Iliyas after the surgery, and his doctor, Dr Rakhi Kusumesh. This is Iliyas’s second corneal implant.

In 2022, the World Health Organization stated that 83 cases in India had possible links to miltefosine intake. While the government issued guidelines in 2022 to prevent people from losing vision after taking miltefosine, there are no plans yet for those who lost eyesight before 2022. Iliyas is one such person. He has so far mostly sought medical help with his own money, and resources. Except for some Ayushman Bharat scheme’s insurance money, Iliyas was on his own for this corneal implant too.

See sunoindia.in/privacy-policy for privacy information.

  continue reading

168集单集

Artwork
icon分享
 
Manage episode 420452803 series 2533765
内容由Suno India提供。所有播客内容(包括剧集、图形和播客描述)均由 Suno India 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In April 2024, that is last month, Suno India published the story featuring Iliyas Marandi, a 23-year-old tribal man who lost his eyesight after taking miltefosine drug for Post-Kala-azar Dermal Leishmaniasis, a skin manifestation of the deadly Kala-azar. This May, he underwent a corneal implant surgery at Indira Gandhi Institute of Medical Sciences. Suno India’s Menaka Rao spoke to Iliyas after the surgery, and his doctor, Dr Rakhi Kusumesh. This is Iliyas’s second corneal implant.

In 2022, the World Health Organization stated that 83 cases in India had possible links to miltefosine intake. While the government issued guidelines in 2022 to prevent people from losing vision after taking miltefosine, there are no plans yet for those who lost eyesight before 2022. Iliyas is one such person. He has so far mostly sought medical help with his own money, and resources. Except for some Ayushman Bharat scheme’s insurance money, Iliyas was on his own for this corneal implant too.

See sunoindia.in/privacy-policy for privacy information.

  continue reading

168集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放